Products

What will AGI do for Adrafinil?

This classification denotes an alpha-adrenergic agonist with the molecular formula C15H15NO3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BI81Z4542G, chemically known as acetohydroxamic acid, 2-((diphenylmethyl)sulfinyl)- but generally known as adrafinil, which bears US NIH Compound Identifier 3033226. European Medicines Agency schedules Adrafinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05278MIG. The term ADRAFINIL is an International Non-Proprietary Name. World Health Organization schedules adrafinil in its Anatomical Therapeutic Chemical (ATC) Classification. ADRAFINIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule adrafinil under HS 29309085 and SITC 51549. As of Q4 2014, ADRAFINIL remains the US FDA Preferred Term for this commodity. Adrafinil bears US NLM identifiers UMLS ID C0101700 and NCI Concept Code C81369. SMILES: S(=O)(C(c1ccccc1)c1ccccc1)CC(=O)NO.